AI-generated summary
In this randomized pilot study of 33 patients with burning mouth syndrome, the authors compared low-level laser therapy with topical clonazepam. Patients given laser therapy reported reduced pain across several measures at 12 weeks after treatment, while the clonazepam group showed less favorable results. The authors describe these findings as preliminary.
- Participants
- 33
- Who or what was studied
- Patients with burning mouth syndrome (25 female, 8 male, mean age 67.12 years)
- Wavelengths
- 980 nm
- Limits stated in the abstract
- The abstract describes the study as a preliminary pilot trial with a small sample split into two groups of 18 and 15 patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 300 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Visual analogue scale, Pilot study, Depression, Anxiety, Photobiomodulation, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.